Increased Mortality in Patients With Differentiated Thyroid Cancer Associated With Graves' Disease
Author(s) -
Gabriella Pellegriti,
Celestina Mannarino,
Marco Russo,
Rosa Terranova,
Ilenia Marturano,
Riccardo Vigneri,
Antonino Belfiore
Publication year - 2013
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2012-2843
Subject(s) - medicine , euthyroid , thyroid cancer , disease , gastroenterology , thyroid , thyroidectomy
We previously reported that differentiated thyroid cancer (DTC) has higher aggressiveness and poorer prognosis in patients with Graves' disease (GD) than DTC in euthyroid control patients. Subsequent studies on this issue reached controversial conclusions. Genetic and environmental factors, as well as the lack of appropriate control subjects and/or inadequate patient follow-up, may account for these discrepancies.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom